Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 , we wish to inform you that the Board of Directors of the Company at their meeting ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rajkamal Synthetics' board approved its audited standalone financial results for Q4 and full year ended March 31, 2025, along with the auditor's report. Statutory auditor ADV & Associates issued an unmodified (clean) opinion on the results. Revenue from operations jumped sharply to Rs. 206.59 lakh for FY25 from just Rs. 10.61 lakh in FY24, while net profit rose to Rs. 22.04 lakh from Rs. 15.16 lakh (up ~45%), with EPS of Rs. 0.34 vs Rs. 0.23. However, the company continues to carry negative other equity of Rs. (616.05) lakh, reflecting accumulated losses, and operating cash flow turned negative at Rs. (22.06) lakh versus a positive Rs. 12.88 lakh last year. The company also received Rs. 7.93 crore during the year towards 25% upfront consideration for 69.85 lakh convertible warrants issued on a preferential basis at Rs. 43.50 per warrant.
While revenue and profit growth look strong, they are coming off a very low base, and the negative net worth and negative operating cash flow remain key concerns for shareholders. The clean audit opinion and incoming warrant funds (Rs. 30.38 crore potential) are positives that could support a stronger balance sheet if the warrant conversion is completed.